Page last updated: 2024-10-26

dipyridamole and Cardiomyopathy, Chagas

dipyridamole has been researched along with Cardiomyopathy, Chagas in 4 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Research Excerpts

ExcerptRelevanceReference
" Dipyridamole (DPY) is an alternative to counteract the pathophysiological phenomena involved in Chagas cardiomyopathy."3.85Dipyridamole potentiated the trypanocidal effect of nifurtimox and improved the cardiac function in NMRI mice with acute chagasic myocarditis. ( Alvarez, C; Bonfante-Cabarcas, R; Bonfante-Rodríguez, R; Caicedo, P; Giraldo, E; Rodríguez-Bonfante, C; Santeliz, S; Yustiz, MD, 2017)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Santeliz, S1
Caicedo, P1
Giraldo, E1
Alvarez, C1
Yustiz, MD1
Rodríguez-Bonfante, C1
Bonfante-Rodríguez, R1
Bonfante-Cabarcas, R1
Tanaka, DM1
de Oliveira, LFL1
Marin-Neto, JA1
Romano, MMD1
de Carvalho, EEV1
de Barros Filho, ACL1
Ribeiro, FFF1
Cabeza, JM1
Lopes, CD1
Fabricio, CG1
Kesper, N1
Moreira, HT1
Wichert-Ana, L1
Schmidt, A1
Higuchi, ML1
Cunha-Neto, E1
Simões, MV1
Petretta, M1
Cuocolo, A1
Kuschnir, E1
Sgammini, H1
Castro, R1
Evequoz, C1
Ledesma, R1

Other Studies

4 other studies available for dipyridamole and Cardiomyopathy, Chagas

ArticleYear
Dipyridamole potentiated the trypanocidal effect of nifurtimox and improved the cardiac function in NMRI mice with acute chagasic myocarditis.
    Memorias do Instituto Oswaldo Cruz, 2017, Volume: 112, Issue:9

    Topics: Acute Disease; Animals; Chagas Cardiomyopathy; Dipyridamole; Disease Models, Animal; Drug Synergism;

2017
Prolonged dipyridamole administration reduces myocardial perfusion defects in experimental chronic Chagas cardiomyopathy.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2019, Volume: 26, Issue:5

    Topics: Animals; Chagas Cardiomyopathy; Cricetinae; Dipyridamole; Disease Models, Animal; Echocardiography;

2019
The long way to defeating Chagas cardiomyopathy.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2019, Volume: 26, Issue:5

    Topics: Cardiomyopathies; Chagas Cardiomyopathy; Chagas Disease; Dipyridamole; Humans

2019
[Chronic Chagas' cardiomyopathy: effects of dipyradamole on ventricular dynamics].
    Arquivos brasileiros de cardiologia, 1983, Volume: 41, Issue:5

    Topics: Adult; Aged; Chagas Cardiomyopathy; Dipyridamole; Female; Heart; Heart Ventricles; Humans; Male; Mid

1983
chemdatabank.com